Coupling of boswellic acid-induced Ca 2+ mobilisation and MAPK activation to lipid metabolism and peroxide formation in human leucocytes

British Journal of Pharmacology

Volumn 141, Issue 2, 2004, Pages 223-232

  Altmann, Anja ^a   Poeckel, Daniel ^a   Fischer, Lutz ^a   Schubert Zsilavecz, Manfred ^a   Steinhilber, Dieter ^a   Werz, Oliver ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Arachidonic acid; Boswellic acids; Ca 2+; Leucocytes; Lipoxygenase; MAPK; Reactive oxygen species

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; BOSWELLIC ACID; CALCIUM ION; CELL CYCLE PROTEIN; LEUKOTRIENE; PERTUSSIS TOXIN; PROTEIN P42; PROTEIN P44; PROTEIN SUBUNIT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ARACHIDONIC ACID METABOLISM; ARTICLE; CALCIUM MOBILIZATION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL TYPE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; FATTY ACID SYNTHESIS; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEUKEMIA CELL; LEUKOCYTE FUNCTION; LIPID METABOLISM; NEUTROPHIL; PEROXIDATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CALCIUM SIGNALING; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; HL-60 CELLS; HUMANS; LEUKOCYTES; LIPID PEROXIDES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES; TRITERPENES;

EID: 1342280380     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705604     Document Type: Article

References (46)

1. ALTMANN, A., FISCHER, L., SCHUBERT-ZSILAVECZ, M., STEINHILBER, D. & WERZ, O. (2002). Boswellic acids activate p42(MAPK) and p38 MAPK and stimulate Ca(2+) mobilization. Biochem. Biophys. Res. Commun., 290, 185-190.
2. BELCHEVA, M.M. & COSCIA, C.J. (2002). Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase. Neurosignals, 11, 34-44.
3. BODEN, S.E., SCHWEIZER, S., BERTSCHE, T., DUFER, M., DREWS, G. & SAFAYHI, H. (2001). Stimulation of leukotriene synthesis in intact polymorphonuclear cells by the 5-lipoxygenase inhibitor 3-oxo-tirucallic acid. Mol. Pharmacol., 60, 267-273.
4. BREITWEG-LEHMANN, E., CZUPALLA, C., STORM, R., KUDLACEK, O., SCHUNACK, W., FREISSMUTH, M. & NURNBERG, B. (2002). Activation and inhibition of G proteins by lipoamines. Mol. Pharmacol., 61, 628-636.
5. CHANOCK, S.J., EL BENNA, J., SMITH, R.M. & BABIOR, B.M. (1994). The respiratory burst oxidase. J. Biol. Chem., 269, 24519-24522.
6. COX, J.A., JENG, A.Y., SHARKEY, N.A., BLUMBERG, P.M. & TAUBER, A.I. (1985). Activation of the human neutrophil nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase by protein kinase C. J. Clin. Invest., 76, 1932-1938.
7. DEWAS, C., FAY, M., GOUGEROT-POCIDALO, M.A. & EL-BENNA, J. (2000). The mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway is involved in formyl-methionyl-leucyl-phenylalanine-induced p47phox phosphorylation in human neutrophils. J. Immunol., 165, 5238-5244.
8. DING, J., VLAHOS, C.J., LIU, R., BROWN, R.F. & BADWEY, J.A. (1995). Antagonists of phosphatidylinositol 3-kinase block activation of several novel protein kinases in neutrophils. J. Biol. Chem., 270, 11684-11691.
9. FORD-HUTCHINSON, A.W., GRESSER, M. & YOUNG, R.N. (1994). 5-LIPOXYGENASE. Annu. Rev. Biochem., 63, 383-417.
10. GERHARDT, H., SEIFERT, F., BUVARI, P., VOGELSANG, H. & REPGES, R. (2001). Therapy of active Crohn disease with Boswellia serrata extract H 15. Z. Gastroenterol., 39, 11-17.
11. GIJON, M.A. & LESLIE, C.C. (1999). Regulation of arachidonic acid release and cytosolic phospholipase A2 activation. J. Leukoc. Biol., 65, 330-336.
12. GLASER, T., WINTER, S., GROSCURTH, P., SAFAYHI, H., SAILER, E.R., AMMON, H.P., SCHABET, M. & WELLER, M. (1999). Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity. Br. J. Cancer, 80, 756-765.
13. GRYNKIEWICZ, G., POENIE, M. & TSIEN, R.Y. (1985). A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260, 3440-3450.
14. GUPTA, I., PARIHAR, A., MALHOTRA, P., GUPTA, S., LUDTKE, R., SAFAYHI, H. & AMMON, H.P. (2001). Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med., 67, 391-395.
15. GUPTA, O.P., SHARMA, N. & CHAND, D. (1992). A sensitive and relevant model for evaluating anti-inflammatory activity-papaya latex-induced rat paw inflammation. J. Pharmacol. Toxicol. Methods, 28, 15-19.
16. HAMPTON, M.B., FADEEL, B. & ORRENIUS, S. (1998). Redox regulation of the caspases during apoptosis. Ann. N. Y. Acad. Sci., 854, 325-328.
17. HANCOCK, J.T. & JONES, O.T. (1987). The inhibition by diphenyleneiodonium and its analogues of superoxide generation by macrophages. Biochem. J., 242, 103-107.
18. HERLAAR, E. & BROWN, Z. (1999). p38 MAPK signalling cascades in inflammatory disease. Mol. Med. Today, 5, 439-447.
19. HEYWORTH, P.G. & BADWEY, J.A. (1990). Protein phosphorylation associated with the stimulation of neutrophils. Modulation of superoxide production by protein kinase C and calcium. J. Bioenerg. Biomembr., 22, 1-26.
20. HOERNLEIN, R.F., ORLIKOWSKY, T., ZEHRER, C., NIETHAMMER, D., SAILER, E.R., SIMMET, T., DANNECKER, G.E. & AMMON, H.P. (1999). Acetyl-11-keto-beta- boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I. J. Pharmacol. Exp. Ther., 288, 613-619.
21. JING, Y., NAKAJO, S., XIA, L., NAKAYA, K., FANG, Q., WAXMAN, S. & HAN, R. (1999). Boswellic acid acetate induces differentiation and apoptosis in leukemia cell lines. Leuk. Res., 23, 43-50.
22. JOHNSON, E.N. & DRUEY, K.M. (2002). Heterotrimeric G protein signaling: role in asthma and allergic inflammation. J. Allergy Clin. Immunol., 109, 592-602.
23. KRIEGLSTEIN, C.F., ANTHONI, C., RIJCKEN, E.J., LAUKOTTER, M., SPIEGEL, H.U., BODEN, S.E., SCHWEIZER, S., SAFAYHI, H., SENNINGER, N. & SCHURMANN, G. (2001). Acetyl-11-keto-beta-boswellic acid, a constituent of a herbal medicine from Boswellia serrata resin, attenuates experimental ileitis. Int. J. Colorectal Dis., 16, 88-95.
24. LIU, J.J., NILSSON, A., OREDSSON, S., BADMAEV, V. & DUAN, R.D. (2002b). Keto-and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in Hep G2 cells via a caspase-8 dependent pathway. Int. J. Mol. Med., 10, 501-505.
25. LIU, J.J., NILSSON, A., OREDSSON, S., BADMAEV, V., ZHAO, W.Z. & DUAN. R.D. (2002a). Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells. Carcinogenesis, 23, 2087-2093.
26. O'FLAHERTY, J.T., TAYLOR, J.S. & KUROKI, M. (2000). The coupling of 5-oxo-eicosanoid receptors to heterotrimeric G proteins. J. Immunol., 164, 3345-3352.
27. PARK, Y.S., LEE, J.H., BONDAR, J., HARWALKAR, J.A., SAFAYHI, H. & GOLUBIC, M. (2002). Cytotoxic action of acetyl-11-keto-beta-boswellic acid (AKBA) on meningioma cells. Planta Med., 68, 397-401.
28. PEREZ, H.D., KELLY, E. & HOLMES, R. (1992). Regulation of formyl peptide receptor expression and its mRNA levels during differentiation of HL-60 cells. J. Biol. Chem., 267, 358-363.
29. QIU, Z.H., GIJON, M.A., DECARVALHO, M.S., SPENCER, D.M. & LESLIE, C.C. (1998). The role of calcium and phosphorylation of cytosolic phospholipase A(2) in regulating arachidonic acid release in macrophages. J. Biol. Chem., 273, 8203-8211.
30. ROOS, D., GOLDSTEIN, I.M., KAPLAN, H.B. & WEISSMANN, G. (1976). Dissociation of phagocytosis, metabolic stimulation and lysosomal enzyme release in human leukocytes. Agents Actions, 6, 256-259.
31. SAFAYHI, H. & SAILER, E.R. (1997). Anti-inflammatory actions of pentacyclic triterpenes. Planta Med., 63, 487-493.
32. SAFAYHI, H., BODEN, S.E., SCHWEIZER, S. & AMMON, H.P. (2000). Concentration-dependent potentiating and inhibitory effects of Boswellia extracts on 5-lipoxygenase product formation in stimulated PMNL. Planta Med., 66, 110-113.
33. SAFAYHI, H., MACK, T., SABIERAJ, J., ANAZODO, M.I., SUBRAMANIAN, L.R. & AMMON, H.P. (1992). Boswellic acids: novel, specific, non-redox inhibitors of 5-lipoxygenase. J. Pharmacol. Exp. Ther., 261, 1143-1146.
34. SAFAYHI, H., RALL, B., SAILER, E.R. & AMMON, H.P. (1997). Inhibition by boswellic acids of human leukocyte elastase. J. Pharmacol. Exp. Ther., 281, 460-463.
35. SAFAYHI, H., SAILER, E.R. & AMMON, H.P. (1995). Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid. Mol. Pharmacol., 47, 1212-1216.
36. SHAO, Y., HO, C.T., CHIN, C.K., BADMAEV, V., MA, W. & HUANG, M.T. (1998). Inhibitory activity of boswellic acids from Boswellia serrata against human leukemia HL-60 cells in culture. Planta Med., 64, 328-331.
37. SHIMIZU, T., MORI, M., BITO, H., SAKANAKA, C., TABUCHI, S., AIHARA, M. & KUME, K. (1996). Platelet-activating factor and somatostatin activate mitogen-activated protein kinase (MAP kinase) and arachidonate release. J. Lipid Mediat. Cell. Signal., 14, 103-108.
38. SIMCHOWITZ, L. & SPILBERG, I. (1979). Generation of superoxide radicals by human peripheral neutrophils activated by chemotactic factor. Evidence for the role of calcium. J. Lab. Clin. Med., 93, 583-593.
39. TAKETO, M.M. & SONOSHITA, M. (2002). Phospholipase A2 and apoptosis. Biochim. Biophys. Acta, 1585, 72-76.
40. WERZ, O., BRUNGS, M. & STEINHILBER, D. (1996). Purification of transforming growth factor beta1 from human platelets. Pharmazie, 51, 893-896.
41. WERZ, O., BUERKERT, E., FISCHER, L., SZELLAS, D., DISHART, D., RADMARK, O., SAMUELSSON, B. & AND STEINHILBER, D. (2002b). Extracellular signal-regulated kinases phosphorylate 5-lipoxygenase and stimulate 5-lipoxygenase product formation in leukocytes. FASEB J., 16, 1441-1443.
42. WERZ, O., BUERKERT, E., SAMUELSSON, B., RADMARK, O. & AND STEINHILBER, D. (2002a). Activation of 5-lipoxygenase by cell stress is calcium-independent in human polymorphonuclear leukocytes. Blood, 99, 1044-1052.
43. WERZ, O., KLEMM, J., SAMUELSSON, B. & RÅDMARK, O. (2000). 5-Lipoxygenase is phosphorylated by p38 kinase dependent MAPKAP kinases. Proc. Natl. Acad. Sci. U.S.A., 97, 5261-5266.
44. WERZ, O., SCHNEIDER, N., BRUNGS, M., SAILER, E.R., SAFAYHI, H., AMMON, H.P.T. & STEINHILBER, D. (1997). A test system for leukotriene synthesis inhibitors based on the in-vitro differentiation of the human leukemic cell lines HL-60 and Mono Mac 6. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 441-445.
45. WERZ, O., SZELLAS, D., HENSELER, M. & STEINHILBER, D. (1998). Nonredox 5-lipoxygenase inhibitors require glutathione peroxidase for efficient inhibition of 5-lipoxygenase activity. Mol. Pharmacol., 54, 445-451.
46. WINKING, M., SARIKAYA, S., RAHMANIAN, A., JODICKE, A. & BOKER, D.K. (2000). Boswellic acids inhibit glioma growth: a new treatment option? J. Neurooncol., 46, 97-103.